Search Results

Bioymifi 100 mg  | Purity Not Available

TargetMol

Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.

More Information Supplier Page

Bioymifi 50 mg  | Purity Not Available

TargetMol

Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.

More Information Supplier Page

Bioymifi 2 mg  | Purity Not Available

TargetMol

Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.

More Information Supplier Page

PFI-2 100 mg  | Purity Not Available

TargetMol

PFI-2 is an effective, specific and cell-active lysine methyltransferase SETD7 inhibitor (Ki/IC50: 0.33/2 nM), 1000-fold selectivity over other methyltransferases and other non-epigenetic targets.

More Information Supplier Page